What happens when you take warfarin with danshen?
Warfarin is a vitamin K antagonist used to prevent clots in atrial fibrillation, after mechanical heart-valve replacement, and after venous thromboembolism. It works by slowing the liver's production of clotting factors II, VII, IX, and X. The international normalised ratio (INR) is the test used to keep the effect inside a safe window, usually 2.0-3.0 (2.5-3.5 for mechanical mitral valves).
Danshen is the dried root of Salvia miltiorrhiza, one of the most widely used herbs in traditional Chinese medicine for cardiovascular conditions. It contains tanshinones (lipid-soluble compounds) and salvianolic acids (water-soluble compounds). Both groups have biological activity relevant to clotting. Tanshinones inhibit platelet aggregation. Salvianolic acids have antithrombotic and fibrinolytic effects in lab models. On top of this pharmacodynamic effect, animal pharmacokinetic studies show that danshen reduces the clearance of both R- and S-warfarin enantiomers, raises warfarin's area under the concentration curve, and prolongs its elimination half-life. Translation: warfarin levels go up and warfarin's effect is amplified.
The clinical consequences in published case reports have been severe. Chan's 2001 review in Annals of Pharmacotherapy summarised three cases of gross over-anticoagulation in patients who added danshen to warfarin. One 62-year-old man developed a haemothorax (bleeding into the chest cavity) with an INR above 8.4 two weeks after starting daily danshen decoctions. A controlled clinical trial later confirmed that two weeks of co-administration significantly prolonged both prothrombin time and INR compared with warfarin alone.
Why is this important?
This is one of the highest-confidence, highest-severity herb-warfarin interactions in the medical literature. Three features set it apart from milder interactions like ginger or feverfew.
First, the mechanism is multi-layered. Danshen pushes warfarin levels up (pharmacokinetic effect) and also adds independent antiplatelet and antithrombotic action (pharmacodynamic effect). When both arms of an interaction operate together, the magnitude is usually larger and the time course can be faster.
Second, the case reports describe major bleeds, not just lab changes. Haemothorax, gastrointestinal bleeding, and intracranial bleeding have all been reported. INR values above 8 carry a steep risk of spontaneous serious bleeding, and danshen has demonstrably pushed patients into that range.
Third, danshen is often taken precisely because the patient has cardiovascular disease. The clinical scenario where danshen and warfarin collide is the patient with atrial fibrillation or a mechanical valve who reaches for a 'natural' heart support product. That is the worst possible combination because the underlying indication for warfarin already implies the patient cannot afford a clotting failure or a major bleed.
What should you do?
Do not start a danshen product if you are on warfarin. If you have started one, contact your anticoagulation clinic now and arrange an INR check as soon as possible, ideally the same day. Do not stop warfarin on your own; over-anticoagulation must be managed with clinical guidance, sometimes with vitamin K, fresh frozen plasma, or prothrombin complex concentrate.
If you are already on a stable danshen-and-warfarin regimen managed by a clinician, do not change the dose of either without telling the clinic. Even stopping the herb can swing the INR in the opposite direction.
Bleeding warning signs that require urgent assessment include chest pain or sudden shortness of breath (which can signal a haemothorax), severe headache, new weakness or vision change, vomiting blood or coffee-ground material, black tarry stools, pink or red urine, a nosebleed lasting more than 10 minutes, and large unexplained bruises. Any of these warrant immediate medical attention.
Before any elective procedure, including dental work, tell the entire team about danshen use. Stop the herb 7-14 days in advance under coordinated guidance.
Which specific products are affected?
The warning covers danshen in every form: dried root, decoctions (boiled water extracts), capsules of powdered root, standardised tanshinone extracts, salvianolic acid extracts, sublingual or dissolvable tablets, and traditional Chinese medicine cardiovascular formulas that include danshen as a component. Branded products include 'Compound Danshen Dripping Pills' (Fufang Danshen Diwan), Danshen tablets, and a variety of multi-herb heart formulas. Many cardiovascular TCM blends list danshen alongside notoginseng (san qi), borneol, and other ingredients; check the herbal ingredient panel.
Danshen is not typically used in cooking, so there is no culinary safe-amount comparable to the situation with garlic, ginger, or turmeric. Any deliberate intake of danshen, whether as a single herb or in a blend, is the concern.
The bottom line
Danshen and warfarin combine through both pharmacokinetic and pharmacodynamic mechanisms, and the published cases include life-threatening bleeds with INRs above 8. This is one of the strongest no-go combinations in herbal pharmacology. Avoid danshen entirely while on warfarin. If you have started a danshen product, contact your anticoagulation clinic immediately and get an INR check. Treat any sign of bleeding, especially chest pain or breathlessness, as a medical emergency.